Core Scientific, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +299.4% | +2.2% | -94.6% | +374.5% | +141.6% | -426.3% | – | +287.6% | +16.2% | +63.2% | -107.6% | – | |
| – | +26.5% | -3.8% | +5.7% | -5.5% | -2.0% | -23.1% | -4.1% | -10.8% | -69.5% | +238.8% | -21.8% | – | |
| – | +17.6% | -106.1% | – | +141.6% | +16.8% | -32.5% | +49.3% | +23.9% | -6.7% | -36.4% | +2.7% | – | |
| – | +194.9% | -49.7% | -40.8% | +316.7% | -92.6% | -31.7% | +503.4% | +118.5% | -13.6% | -67.1% | -363.0% | – | |
| – | +324.7% | +173.9% | -90.2% | +890.4% | -7.4% | +192.1% | +44.4% | +109.9% | +7.9% | +41.6% | +45.2% | – | |
| – | – | -1,454.7% | -90.0% | +881.2% | -7.8% | +209.1% | +34.4% | +112.7% | +7.5% | +41.5% | +105.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +227.0% | -100.7% | +18.1% | -89.6% | -100.0% | – | +230.1% | – | |
| – | +18.9% | – | -127.9% | – | +228.3% | -100.7% | +656.8% | -83.2% | +309.6% | – | +128.6% | – | |
| – | – | +672.9% | -138.5% | – | +272.2% | -123.7% | – | – | – | – | +86.4% | – | |
| – | +273.6% | -196.6% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.